Эта страница была переведена автоматически, точность перевода не гарантируется. Пожалуйста, обратитесь к английской версии для исходного текста.

An Observational Study Measuring in a Non-invasive Approach the Nociception Level Index and Its Association With Pain and Anxieiy Perception Evaluated by Questionnaires, in Awake Women During Elective Cesarean Delivery Under Spinal Anesthesiaanxiety

22 июля 2026 г. обновлено: Michael Grach

A Prospective Observational Study Evaluating the Nociception Level Index and Its Association With Pain Perception, Anxiety, Uterine Activity, and Autonomic Responses During Elective Cesarean Delivery Under Spinal Anesthesia

The Nociception Level (NOL) Index is a multiparametric, non-invasive monitor that objectively assesses nociception by integrating several autonomic physiological signals. Although the NOL Index has been extensively validated during general anesthesia, its performance in awake patients undergoing regional anesthesia remains poorly understood. During cesarean delivery (CD) under spinal anesthesia, autonomic responses may be influenced not only by nociceptive stimulation but also by anxiety, uterine contractions, hemodynamic changes, uterotonic medications, and other non-nociceptive factors. Understanding the relative contribution of these factors is essential before the NOL Index can be reliably applied in awake surgical patients.

This prospective observational study aims to characterize the behavior of the NOL Index throughout elective CD performed under spinal anesthesia and to evaluate its relationship with subjective pain intensity, anxiety, uterine activity, perioperative autonomic responses, and routine physiological variables.

Approximately 100 women undergoing elective CD under spinal anesthesia will be enrolled at Carmel Medical Center. Continuous NOL monitoring using the PMD-200 system will be performed from before spinal anesthesia until the early postoperative period. Subjective pain (Visual Analog Scale), anxiety (Visual Analog Scale for Anxiety), uterine activity, hemodynamic variables, perioperative medications, and predefined surgical events will be prospectively recorded and synchronized with continuous NOL measurements. Potential confounding factors, including vasopressor administration, uterotonic drugs, nausea, shivering, patient movement, and supplemental analgesia, will also be documented.

This study will provide one of the first comprehensive evaluations of continuous NOL monitoring during CD under spinal anesthesia. The results are expected to improve the understanding of objective nociception monitoring in awake patients, clarify the influence of non-nociceptive autonomic activation on the NOL Index, and help define the clinical role and limitations of NOL monitoring during regional anesthesia, and may contribute to the future development of objective pain assessment strategies in obstetric anesthesia and other clinical settings involving awake patients.

Обзор исследования

Статус

Еще не набирают

Подробное описание

Elective cesarean delivery performed under spinal anesthesia provides a unique and highly reproducible clinical model for investigating objective nociception monitoring in awake patients. Unlike patients undergoing general anesthesia, women receiving spinal anesthesia remain conscious throughout surgery, allowing simultaneous assessment of subjective pain perception, anxiety, autonomic physiological responses, and objective nociception monitoring under standardized surgical conditions.

The Nociception Level (NOL) Index is a multiparametric physiological monitoring system that integrates several autonomic variables, including heart rate variability, skin conductance, photoplethysmographic waveform characteristics, and additional physiological parameters using a proprietary machine-learning algorithm. The NOL Index has been extensively validated during general anesthesia and has demonstrated good correlation with surgical stimulation and analgesic adequacy. However, its performance during regional anesthesia, particularly in awake obstetric patients, remains insufficiently characterized.

During cesarean delivery under spinal anesthesia, multiple physiological and psychological factors may influence autonomic nervous system activity independently of nociceptive stimulation. These include preoperative and intraoperative anxiety, emotional stress, patient communication, uterine manipulation, uterine contractions following administration of uterotonic agents, hemodynamic changes associated with neuraxial anesthesia, vasopressor administration, nausea, shivering, and patient movement. Consequently, interpretation of the NOL Index in this setting requires further clinical investigation.

This prospective, single-center observational study will enroll approximately 100 women undergoing elective cesarean delivery under spinal anesthesia at Carmel Medical Center, Haifa, Israel. Standard perioperative management will not be modified for study purposes. Continuous NOL monitoring will begin before initiation of spinal anesthesia and continue throughout surgery and the early postoperative recovery period.

Simultaneously, subjective pain intensity will be assessed using the Visual Analog Scale (VAS), anxiety will be evaluated using the Visual Analog Scale for Anxiety (VAS-A), and routine physiological variables including heart rate, blood pressure, mean arterial pressure, and oxygen saturation will be recorded. Surgical milestones, administration of intrathecal medications, uterotonic agents, vasopressors, rescue analgesia, and other clinically relevant medications will be prospectively documented and synchronized with continuous NOL recordings.

The primary objective of the study is to characterize the intraoperative behavior of the NOL Index and determine the percentage of monitoring time during which NOL values remain outside the predefined target range of 10-25. Secondary objectives include evaluation of the relationships between the NOL Index and subjective pain intensity, anxiety, uterine activity, surgical phases, rescue analgesia requirements, and perioperative autonomic responses.

Potential confounding factors known to influence autonomic nervous system activity-including maternal anxiety, hypotension, vasopressor administration, uterotonic medications, nausea, shivering, supplemental analgesia, sedation, and patient movement-will be prospectively documented and considered during statistical analyses. Continuous NOL data will be automatically recorded according to the device sampling frequency and exported for offline analysis following predefined quality-control procedures.

The findings of this study are expected to improve understanding of objective nociception monitoring in awake patients undergoing regional anesthesia and to define the clinical utility and limitations of the NOL Index in obstetric anesthesia. The results may contribute to optimizing intraoperative pain assessment, improving interpretation of physiological monitoring during regional anesthesia, and guiding future research on objective nociception monitoring in conscious surgical patients.

Тип исследования

Наблюдательный

Регистрация (Оцененный)

100

Контакты и местонахождение

В этом разделе приведены контактные данные лиц, проводящих исследование, и информация о том, где проводится это исследование.

Контакты исследования

  • Имя: Michael Grach, MD Dr.
  • Номер телефона: +972506265753
  • Электронная почта: Grachm@gmail.com

Учебное резервное копирование контактов

  • Имя: Dana Kosh, MD Dr.
  • Номер телефона: 972- 4-8250785
  • Электронная почта: Danako@clalit.org.il

Места учебы

      • Haifa, Израиль, 3436212
        • Carmel Medical Center
        • Контакт:
          • Michael Grach, MD Dr.
          • Номер телефона: 972-506265753
          • Электронная почта: Grachm@gmail.com
        • Контакт:
          • Dana Kosh, MD Dr.
          • Номер телефона: 972-4-8250785
          • Электронная почта: danako@clalit.org.il

Критерии участия

Исследователи ищут людей, которые соответствуют определенному описанию, называемому критериям приемлемости. Некоторыми примерами этих критериев являются общее состояние здоровья человека или предшествующее лечение.

Критерии приемлемости

Возраст, подходящий для обучения

  • Взрослый

Принимает здоровых добровольцев

Нет

Метод выборки

Невероятностная выборка

Исследуемая популяция

Women ≥18 years, ASA I-III, scheduled to elective cesarean delivery under spinal anesthesia

Описание

Inclusion Criteria:

  • Women ≥18 years
  • Scheduled to elective cesarean delivery under spinal anesthesia
  • ASA I-III
  • Able to provide informed consent

Exclusion Criteria:

  • Women Age <18 years
  • BMI >35 kg/m²
  • Major psychiatric illness
  • Chronic psychotropic/anxiolytic therapy
  • Substance abuse
  • Inability to communicate
  • Contraindication to spinal anesthesia
  • Any pre condition interfering with study participation

Учебный план

В этом разделе представлена ​​подробная информация о плане исследования, в том числе о том, как планируется исследование и что оно измеряет.

Как устроено исследование?

Детали дизайна

Что измеряет исследование?

Первичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
Percentage of intraoperative monitoring time during which the Nociception Level Index remains outside the predefined target range (10-25) during elective cesarean delivery under spinal anesthesia
Временное ограничение: Intraoperative period up to 3 hours
Nociception Level Index a physiological parameter measurment obtained, in a non invasive way, by a probe attached to the index finger, recording every 5 seconds. (range 0-100) 0 no pain 100 worst pain
Intraoperative period up to 3 hours

Вторичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
Duration of Nociception Level Index (>25)
Временное ограничение: Intraoperative period and approximately 1 hour postoperatively, up to 5 hours
Nociception Level Index a physiological parameter measurment obtained, in a non invasive way, by a probe attached to the index finger, recording every 5 seconds. (range 0-100) 0 no pain 100 worst pain. Recording duration when values exceeding over 25
Intraoperative period and approximately 1 hour postoperatively, up to 5 hours
Correlation between Nociception Level Index and Visual Analog Scale
Временное ограничение: : Intraoperative period and approximately 1 hour postoperatively up to 5 hours
Correlation between Nociception Level Index a physiological parameter measurment obtained, in a non invasive way, by a probe attached to the index finger, recording every 5 seconds. (range 0-100) 0 no pain 100 worst pain and Visual analog scale scores by questionnaires, range 1-10 at 3 time points: preoperative, 0- no pain 10 worst pain
: Intraoperative period and approximately 1 hour postoperatively up to 5 hours
Correlation between Nociception Level Index and Visual Analogue Scale- anxiety
Временное ограничение: Intraoperative period and approximately 1 hour postoperatively up to 5 hours
Correlation between Nociception Level Index a physiological parameter measurment obtained, in a non invasive way, by a probe attached to the index finger, recording every 5 seconds. (range 0-100) 0 no pain 100 worst pain and Visual analog scale- Anxiety scores by questionnaires, range 1-10 at 3 time points: preoperative, 0- no pain 10 worst pain
Intraoperative period and approximately 1 hour postoperatively up to 5 hours
Surgical phase analysis
Временное ограничение: Intraoperative period and approximately 1 hour postoperatively
Intraoperative period and approximately 1 hour postoperatively
Association of Nociception Level Index with uterine activity
Временное ограничение: Intraoperative period and approximately 1 hour postoperatively up to 5 hours
Nociception Level Index a physiological parameter measurment obtained, in a non invasive way, by a probe attached to the index finger, recording every 5 seconds. (range 0-100) 0 no pain 100 worst pain. Uterine activity as assessed by the surgeon to determine unterine contrations
Intraoperative period and approximately 1 hour postoperatively up to 5 hours
Rescue analgesia requirements
Временное ограничение: Intraoperative period and approximately 1 hour postoperatively up to 5 hours
Recording analgesia requirements dosages
Intraoperative period and approximately 1 hour postoperatively up to 5 hours

Соавторы и исследователи

Здесь вы найдете людей и организации, участвующие в этом исследовании.

Спонсор

Публикации и полезные ссылки

Лицо, ответственное за внесение сведений об исследовании, добровольно предоставляет эти публикации. Это может быть что угодно, связанное с исследованием.

Общие публикации

Даты записи исследования

Эти даты отслеживают ход отправки отчетов об исследованиях и сводных результатов на сайт ClinicalTrials.gov. Записи исследований и сообщаемые результаты проверяются Национальной медицинской библиотекой (NLM), чтобы убедиться, что они соответствуют определенным стандартам контроля качества, прежде чем публиковать их на общедоступном веб-сайте.

Изучение основных дат

Начало исследования (Оцененный)

15 августа 2026 г.

Первичное завершение (Оцененный)

30 июля 2027 г.

Завершение исследования (Оцененный)

30 июля 2027 г.

Даты регистрации исследования

Первый отправленный

11 июля 2026 г.

Впервые представлено, что соответствует критериям контроля качества

22 июля 2026 г.

Первый опубликованный (Действительный)

24 июля 2026 г.

Обновления учебных записей

Последнее опубликованное обновление (Действительный)

24 июля 2026 г.

Последнее отправленное обновление, отвечающее критериям контроля качества

22 июля 2026 г.

Последняя проверка

1 июля 2026 г.

Дополнительная информация

Термины, связанные с этим исследованием

Планирование данных отдельных участников (IPD)

Планируете делиться данными об отдельных участниках (IPD)?

НЕ РЕШЕНО

Описание плана IPD

IPD sharing will be decided depending on requirement for publication or demand by researcher

Информация о лекарствах и устройствах, исследовательские документы

Изучает лекарственный продукт, регулируемый FDA США.

Нет

Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.

Нет

Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .

Подписаться